$EORTC 22972-26991/MRC BR10 trial: fractionated stereotactic boost following conventional radiotherapy of high grade gliomas. Clinical and quality-assurance results of the stereotactic boost arm$

EORTC 22972-26991/MRC BR10 trial: fractionated stereotactic boost following conventional radiotherapy of high grade gliomas. Clinical and quality-assurance results of the stereotactic boost arm

The EORTC trial No. 22972 investigated the role of an additional fractionated stereotactic boost (fSRT) to conventional radiotherapy for patients with high grade gliomas. A quality-assurance (QA) programme was run in conjunction with the study and was the first within the EORTC addressing the qualit...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Radiotherapy and oncology 2008-08, Vol.88 (2), p.163
Hauptverfasser:	Baumert, Brigitta G, Brada, Michael, Bernier, Jacques, Kortmann, Rolf D, Dehing-Oberije, Cary, Collette, Laurence, Davis, J Bernard
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Brain Neoplasms - radiotherapy Cranial Irradiation - methods Cranial Irradiation - standards Dose Fractionation Female Glioma - radiotherapy Humans Male Middle Aged Quality Assurance, Health Care Stereotaxic Techniques Surveys and Questionnaires Survival Analysis Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!